For research use only. Not for therapeutic Use.
HPK1-IN-8 is an allosteric, inactive conformation-selective inhibitor of full-length HPK1.
Catalog Number | I045330 |
CAS Number | 1214561-09-7 |
Synonyms | 2-(3,7-dimethyl-5-oxo-1H-[1,2,4]triazolo[4,3-a]pyrimidin-6-yl)-N-[5-[(2-fluorophenyl)methyl]-1,3-thiazol-2-yl]acetamide |
Molecular Formula | C19H17FN6O2S |
Purity | ≥95% |
InChI | InChI=1S/C19H17FN6O2S/c1-10-14(17(28)26-11(2)24-25-18(26)22-10)8-16(27)23-19-21-9-13(29-19)7-12-5-3-4-6-15(12)20/h3-6,9H,7-8H2,1-2H3,(H,22,25)(H,21,23,27) |
InChIKey | DKCQZXASVNYNLW-UHFFFAOYSA-N |
SMILES | CC1=C(C(=O)N2C(=NNC2=N1)C)CC(=O)NC3=NC=C(S3)CC4=CC=CC=C4F |
Reference | [1]. Wang W, et al. Discovery of an Allosteric, Inactive Conformation-Selective Inhibitor of Full-Length HPK1 Utilizing a Kinase Cascade Assay. Biochemistry. 2021 Oct 19;60(41):3114-3124. |